Association Between the Duration of Ischemic Heart Disease and Erosive Gastroduodenal Mucosal Lesions
Received: 2026-07-26
Published: 2026-09-30
Abstract
Aim. To evaluate the association between the duration of ischemic heart disease (IHD) and erosive gastroduodenal lesions detected by esophagogastroduodenoscopy.
Materials and methods. This retrospective cross-sectional study included 2,924 patients with IHD. Patients were divided according to disease duration into ≤1 year (n = 414) and >1 year (n = 2,510) groups.
Results. Gastric erosions were detected in 14.25% and 11.67% of patients, respectively, with no statistically significant difference (χ2 = 2.23; p = 0.135). Univariable logistic regression also showed no significant association between IHD duration and overall gastric erosions (OR = 0.795; 95% CI, 0.588–1.075), and no significant associations were found for solitary, multiple, antral, fundal, or duodenal bulb erosions. The association with overall gastric erosions remained non-significant after adjustment for age and sex.
Conclusion. IHD duration was not significantly associated with erosive gastric or duodenal lesions in this study.
Keywords
List of references
-
Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720-3826. https://doi.org/10.1093/eurheartj/ehad191.
-
Abraham NS, Barkun AN, Sauer BG, et al. American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period. Am J Gastroenterol. 2022;117(4):542-558. https://doi.org/10.14309/ajg.0000000000001627.
-
Lanas A, Wu P, Medin J, Mills EJ. Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis. Clin Gastroenterol Hepatol. 2011;9(9):762-768.e6. https://doi.org/10.1016/j. cgh.2011.05.020.
-
Patrono C, Rocca B. Aspirin: promise and resistance in the new millennium. Arterioscler Thromb Vasc Biol. 2008;28(3):25-32. https://doi.org/10.1161/ATVBAHA.107.16048.
-
Malfertheiner P, Megraud F, Rokkas T, et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022;71(9):1724-1762. https://doi.org/10.1136/gutjnl-2022-327745.
-
Bhatt DL, Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. J Am Coll Cardiol. 2008;52(18):1502-1517. https://doi.org/10.1016/j.jacc.2008.08.002.
-
Chan FK, Ching JY, Hung LC, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med. 2005;352(3):238-244. https://doi.org/10.1056/NEJMoa042087.
-
Valkhoff VE, Sturkenboom MCJM, Hill C, Veldhuyzen van Zanten S, Kuipers EJ. Low-dose acetylsalicylic acid use and the risk of upper gastrointestinal bleeding: a meta-analysis of randomized clinical trials and observational studies. Can J Gastroenterol. 2013;27(3):159-167. https://doi.org/10.1155/2013/596015.
-
García Rodríguez LA, Martín-Pérez M, Hennekens CH, Rothwell PM, Lanas A. Bleeding risk with long-term low-dose aspirin: a systematic review of observational studies. PLoS One. 2016;11(8):e0160046. https://doi.org/10.1371/journal.pone.0160046.
-
Abraham NS. New clinical paradigms for treating and preventing antiplatelet gastrointestinal bleeding. Curr Opin Gastroenterol. 2017;33(6):467-472. https://doi.org/10.1097/MOG.000000000000039.
-
Sung JJY, Chiu PWY, Chan FKL, et al. Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018. Gut. 2018;67(10):1757-1768. https://doi.org/10.1136/gutjnl-2018-316276.
-
Gralnek IM, Stanley AJ, Morris AJ, et al. Endoscopic diagnosis and management of nonvariceal up-per gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) Guideline—Update 2021. Endoscopy. 2021;53(3):300-332. https://doi.org/10.1055/a-1369-5274.
-
Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol. 2012;107(3):345-
-
Abraham NS, Hlatky MA, Antman EM, et al. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. J Am Coll Cardiol. 2010;56(24):2051-2066. https://doi.org/10.1016/j.jacc.2010.09.010.
-
Daminova LT, Kodirov ShS, Shek AB. Risk of gastrointestinal bleeding in patients with ischemic heart disease. O’zbekiston kardiologiyasi. 2019;(4):54.
About the Authors
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
